Search

1. The Elijah E. Cummings Lower Drug Costs Now Act: how it would work, how it would affect prices, and what the challenges are

Author(s):

Ginsburg, Paul B., author
Lieberman, Steven M., author

Publication:

[New York, N.Y.] : The Commonwealth Fund, April 2020

Subject(s):

Cost Control
Drug Costs -- legislation & jurisprudence
United States

2. Cost savings

Author(s):

Steiner, David J., author

Publication:

[Toronto, Ontario] : Thomson Reuters, 23-December-2019

Subject(s):

Cost Control -- legislation & jurisprudence
Cost Savings
Drug Costs -- legislation & jurisprudence
Economics, Pharmaceutical
Legislation, Drug
United States

3. CBO's model of drug price negotiations under the Elijah E. Cummings Lower Drug Costs Now Act

Author(s):

Adams, Christopher, author
Herrnstadt, Evan, author

Publication:

[Washington, DC] : Congressional Budget Office, February 2021

Subject(s):

Cost Control -- legislation & jurisprudence
Drug Costs -- legislation & jurisprudence
Models, Economic
Negotiating
United States

4. Cost savings

Author(s):

Steiner, David J., author

Publication:

[Toronto, Ontario] : Thomson Reuters, 20-December-2021

Subject(s):

Cost Savings
Drug Costs -- legislation & jurisprudence
Legislation, Drug
Prescription Drugs -- economics
State Government
United States

5. Medicare Part D

Author(s):

Steiner, David J., author

Publication:

[Toronto, Ontario] : Thomson Reuters, 19-December-2022

Subject(s):

Medicare Part D -- economics
Medicare Part D -- legislation & jurisprudence
Drug Costs -- legislation & jurisprudence
United States
Centers for Medicare & Medicaid Services (U.S.)

6. Cost savings

Author(s):

Steiner, David J., author

Publication:

[Toronto, Ontario] : Thomson Reuters, 19-December-2022

Subject(s):

Cost Savings -- legislation & jurisprudence
Drug Costs -- legislation & jurisprudence
State Government
United States

7. Projected impacts for Asian Medicare enrollees

Publication:

Washington, D.C. : Office of the Assistant Secretary for Planning and Evaluation, Office of Health Policy, 2023

Subject(s):

Asian
Drug Costs -- legislation & jurisprudence
Forecasting
Medicare Part D -- economics
Medicare Part D -- legislation & jurisprudence
United States
United States.

8. Projected impacts for Latino Medicare enrollees

Publication:

Washington, D.C. : Office of the Assistant Secretary for Planning and Evaluation, Office of Health Policy, September 25, 2023

Subject(s):

Cost Savings
Drug Costs -- legislation & jurisprudence
Forecasting
Hispanic or Latino
Medicare Part D -- economics
Medicare Part D -- legislation & jurisprudence
United States
United States.

9. Medicare Part D and beneficiaries could realize significant spending reductions with increased biosimilar use

Publication:

Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, March 2022

Subject(s):

Biosimilar Pharmaceuticals
Drug Costs -- legislation & jurisprudence
Government Regulation
Medicare Part D -- economics
United States
United States. Department of Health and Human Services
Centers for Medicare & Medicaid Services (U.S.)

10. 340B Drug Discount Program: oversight of the Intersection with the Medicaid Drug Rebate Program needs improvement : report to Congressional requesters

Publication:

Washington, DC : United States Government Accountability Office, January 2020

Subject(s):

Drug Costs -- legislation & jurisprudence
Government Regulation
Medicaid -- economics
United States
United States. Department of Health and Human Services